(redirected from Mycobacterium infections)
Also found in: Thesaurus, Medical, Encyclopedia.


n. pl. my·co·bac·te·ri·a (-tîr′ē-ə)
Any of various rod-shaped, aerobic, often pathogenic bacteria of the genus Mycobacterium, including the causative agents of tuberculosis and leprosy.

my′co·bac·ter′i·al adj.


n, pl -ria (-rɪə)
(Microbiology) any of the rod-shaped Gram-positive bacteria of the genus Mycobacterium, some of which cause human diseases, such as tuberculosis and leprosy


(ˌmaɪ koʊ bækˈtɪər i əm)

n., pl. -te•ri•a (-ˈtɪər i ə)
any of several rod-shaped aerobic bacteria of the genus Mycobacterium, certain species of which, as M. tuberculosis, are pathogenic.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.mycobacterium - rod-shaped bacteria some saprophytic or causing diseases
eubacteria, eubacterium, true bacteria - a large group of bacteria having rigid cell walls; motile types have flagella
genus Mycobacterium - nonmotile Gram-positive aerobic bacteria


n. L. Mycobacterium, especie de bacterias gram-positivas en forma de bastoncillo que incluyen bacterias causantes de la lepra y la tuberculosis.
References in periodicals archive ?
They strain typed M avium and M intracellulare isolates from captive birds and found no correlation between the strain and the location in which the birds were housed, indicating that mycobacterium infections were likely acquired from naturally occurring mycobacteria in the environment.
The most common atraumatic causes include malignancy, cirrhosis, and Mycobacterium infections. In the setting of Mycobacterium infections, histology has shown well-formed granulomas in lymphatic vessels causing lymphatic obstruction at the base of the mesentery or the cisterna chyli.
Characteristics of 334 nontuberculous mycobacterium infections, Oregon, USA, 2007-2012 * Infection site ([dagger]) Skin/soft tissue, Disseminated, Category n = 197 n = 57 Annual incidence/100,000 0.9 0.2 population Patient demographics Sex F 115 (58) 19 (33) M 82 (42) 38 (67) Median age, y (range) 51 (0.8-92) 41 (1 -82) HIV positive 8 (4) 34 (60) Mycobacterium species Rapid-growing species 85 (43.1) 5 (8.8) M.
US-based Matinas BioPharma has started dosing in the Phase 1 clinical study of its lead antibiotic product candidate MAT2501, under development for the treatment of nontuberculous mycobacterium infections (NTM) in an initial indication, it was reported on Tuesday.

Full browser ?